ENIOLA BUZOMBO: Open Payments
NPI 1306577226 · BELLAIRE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 4 payments from 4 companies in 2025. Trend: 2023 $125 · 2024 $611 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $119 |
| AstraZeneca Pharmaceuticals LP | 1 | $116 |
| Phadia US Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $14 |
Products named: Auvelity, AIRSUPRA, ImmunoCAP, Rybelsus.
Industry payments across TX — which companies pay providers there.
